Cargando…
An Evaluation of Systemic Vancomycin Dosing in Obese Patients
We retrospectively identified 67 patients with severe or morbid obesity (body mass index ≥35 kg/m(2)) who had received intravenous vancomycin at our institution. We observed that an initial dose of 45 to 65 mg/kg vancomycin per day based upon ideal body weight rather than actual body weight was more...
Autores principales: | Kubiak, David W., Alquwaizani, Mohammed, Sansonetti, David, Barra, Megan E., Calderwood, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691676/ https://www.ncbi.nlm.nih.gov/pubmed/26716105 http://dx.doi.org/10.1093/ofid/ofv176 |
Ejemplares similares
-
393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014) -
Evaluation of Vancomycin Accumulation in Patients With Obesity
por: Assadoon, Maha S, et al.
Publicado: (2022) -
1102. Evaluation of Vancomycin Accumulation in Patients with Obesity
por: Assadoon, Maha, et al.
Publicado: (2021) -
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis
por: Johnson, Jennifer A., et al.
Publicado: (2015) -
Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
por: Bradley, Nicole, et al.
Publicado: (2023)